Clinical Trials On-Line - Physican: Przemyslaw Twardowski

The following is a list of available studies directed by Przemyslaw Twardowski, MD

Search results: 4 Clinical trial(s) found (Page 1 of 1 )

Results per page: 25 50 100 All

1-4 Trials

Jump to page:

Click here to generate a printer-friendly view

COH Protocol Number: 12284

ClinicalTrials.gov Number: NCT01576172

Principal Investigator: Przemyslaw Twardowski, MD

Sponsor: NCI Approved External Peer Review

Title:

PHII-123, NCI 9012: A Randomized Gene Fusion Stratified Phase 2 Trial of Abiraterone with or without ABT-888 for Patients with Metastatic Castration-Resistant Prostate Cancer

Summary
English

Full Eligibility
Criteria

PI's Profile

COH Protocol Number: 12281

ClinicalTrials.gov Number: NCT01688973

Principal Investigator: Przemyslaw Twardowski, MD

Sponsor: Cooperative Group

Title:

SWOG S1107: Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Papillary Renal Cell Carcinoma

Summary
English

Full Eligibility
Criteria

PI's Profile

COH Protocol Number: 11194

ClinicalTrials.gov Number: NCT01309672

Principal Investigator: Przemyslaw Twardowski, MD

Sponsor: Cooperative Group

Title:

SWOG S1014: Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II

Summary
English

Summary
Spanish

Full Eligibility
Criteria

PI's Profile

COH Protocol Number: 11193

ClinicalTrials.gov Number: NCT01454089

Principal Investigator: Przemyslaw Twardowski, MD

Sponsor: Industrial

Title:

A Randomized, Double-Blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination with OGX-427 or Placebo in Patients with Advanced Transitional Cell Carcinoma

Summary
English

Summary
Spanish

Full Eligibility
Criteria

PI's Profile


Results per page: 25 50 100 All	1-4 Trials	Jump to page:

City of Hope

Page Title

Global Navigation